Leading Drug Stock Fights To Regain Buy Point At Key Resistance Level

Today's Spotlight BREAKING: Carvana, Comfort Systems, CRH To Join S&P 500 Neurocrine Biosciences (NBIX) is this week's Big Cap 20 pick to watch, as the drug stock is back inside a 5% buy zone from a recent entry. The biotech has a few flagship drugs. Among them are Crenessity, which treats classic congenital adrenal hyperplasia. It also has Ingrezza, a treatment for the movement disorders known as tardive dyskinesia and chorea,… MarketSurge Cyber Week Sale This week, save over 80% on MarketSurge—get 2 month ...